Shopping Cart
Remove All
Your shopping cart is currently empty
Efipladib is a phospholipase inhibitor. Efipladib decreases nociceptive responses without affecting PGE2 levels in the cerebral spinal fluid.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,970 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $2,580 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $3,400 | 8-10 weeks | 8-10 weeks |
| Description | Efipladib is a phospholipase inhibitor. Efipladib decreases nociceptive responses without affecting PGE2 levels in the cerebral spinal fluid. |
| Targets&IC50 | cPLA2α:0.04 μM, cPLA2α:0.067 μM (Ki) |
| Synonyms | PLA-902, PLA902, PLA 902 |
| Molecular Weight | 746.14 |
| Formula | C40H35Cl3N2O4S |
| Cas No. | 381683-94-9 |
| Relative Density. | 1.32 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.